Tag Archives: Cognitive Impairment in Parkinson’s Disease

Cognitive Impairment in Parkinson’s Disease: the State of Current Understanding (NPJ Parkinson’s Disease)

Posted on July 9, 2018 by Dementia and Elderly Care News

Summary The following review summarises a recent conference on the topic of cognitive impairment encountered in Parkinson’s Disease. Full Text Link Reference Goldman, JG. Vernaleo, BA. [and] Camicioli, R. [et al] (2018). Cognitive impairment in Parkinson’s disease: a report from … Continue reading →

Posted in Acute Hospitals, Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Parkinson's Disease, Person-Centred Care, Quick Insights, Statistics, Universal Interest | Tagged Barrow Neurological Institute (Phoenix), Boston University, Boston University Medical Campus, Canada, Center for Neuromodulation: Barrow Neurological Institute, Center for Neurorehabilitation: Boston University, Charles E. Schmidt College of Medicine: Florida Atlantic University, Cognitive Decline, Cognitive Impairment, Cognitive Impairment in Parkinson's Disease, College of Health Sciences: Rush University Medical Center, Department of Clinical and Health Psychology: University of Florida, Department of Clinical Neuropsychology: Barrow Neurological Institute, Department of Clinical Nutrition: Rush University Medical Center, Department of Health and Aging: Rush University Medical Center, Department of Medicine: University of Alberta, Department of Medicine: University of Pennsylvania, Department of Neurological Sciences: Rush University Medical Center, Department of Neurology: Boston University Medical Campus, Department of Neurology: University of Iowa, Department of Neurology: University of Maryland School of Medicine, Department of Neurology: University of Miami, Department of Neurology: University of Pennsylvania, Department of Physical Therapy and Athletic Training: Boston University, Department of Psychiatry and Psychology: Mayo Clinic (Rochester), Department of Psychiatry: Rutgers The State University of New Jersey, Division of Neuropsychology: University of Miami, Edmond J Safra Program in Parkinson’s Disease: Toronto Western Hospital, Florida Atlantic University, Lewy Body Parkinson Disease, MCI: Mild Cognitive Impairment, Mediterranean-DASH Intervention for Neurodegenerative Delay: MIND, Memory Controllability Inventory (MCI), Mild Cognitive Impairment in Parkinson's Disease (MCI-PD), Morton and Gloria Shulman Movement Disorders Centre: Toronto Western Hospital, Movement Disorder Society (MDS) Task Forces for PDD and PD-MCI Diagnostic Criteria, Neurology Service: Iowa City, NPJ Parkinson’s Disease, Parkinson's Disease Foundation Community Choice Research Award Program, Parkinson's Foundation, Parkinson’s Dementia, Parkinson’s Disease Dementia, PD Cognitive Impairment, Pre-Dementia (MCI), Risk of Cognitive Impairment and Dementia, Rush University Medical Center, Rutgers The State University of New Jersey, Section of Parkinson Disease and Movement Disorders: Rush University Medical Center, Toronto Western Hospital, United States, University Health Network: University of Toronto, University of Alberta, University of Florida, University of Iowa, University of Maryland School of Medicine, University of Miami, University of Pennsylvania, University of South Florida, University of Toronto, Unmet Needs, USA, Veterans Affairs Health Care System (Iowa City) | Leave a comment

Issues in the Clinical Diagnosis of Dementia with Lewy Bodies (Translational Neurodegeneration)

Posted on February 24, 2013 by Dementia and Elderly Care News

Summary This article discusses recent progress, and problems remaining, in the clinical diagnosis of Dementia with Lewy Bodies (DLB). The sensitivity of accurate clinical diagnosis of DLB is said to be low. It seems likely that it may be possible … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Universal Interest | Tagged (123)I-FP-CIT: (123)I-2beta-carbometoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane, Aβ Deposition in DLB, Amyloid Beta Protein, Antipsychotics: Neuroleptic Sensitivity, Assessment of Fluctuation Scales, Australia, Beta-Amyloid, Beta-Amyloid Plaques, CIND-PD: Cognitive Impairment in Parkinson's Disease, Cognitive Impairment in Parkinson's Disease, Cognitive Impairment in Parkinson's Disease (CIND-PD), DaTSCAN, Delusional Ideas, Delusions, Dementia in Parkinson's Disease, Dementia with Lewy Bodies, Dementia With Lewy Bodies (DLB), Dementia with Lewy Bodies Symptoms, Dementia with Lewy Bodies Translational Neurodegeneration, Diagnosis and Management of Dementias of Lewy Body Type in the NHS (DIAMAND-Lewy), Diagnosis and Screening: Dementia with Lewy Bodies, Differential Diagnosis, DLB: Dementia with Lewy Bodies, Dopamine, Dopamine Denervation, Early Differential Diagnosis, Fluctuating Cognition, Fluctuation Assessment Scales, Frederick Lewy, Genetics of DLB, Glucocerebrosidase Gene Mutations, Hallucinations, Hallucinations in People with Dementia, I-123 MIBG: Iodine-123 Metaiodobenzilguanidine, α-Synuclein, β-amyloid, β-amyloid Deposition, β-Amyloid Oligomerization, β-Synuclein, γ-Synuclein, Lewy Body Degeneration, Lewy Body Dementia, Lewy-Related Pathologies (LRP), Low Dopamine Transporter Uptake, LRP: Lewy-Related Pathology, Neuroleptic Sensitivity, Neuroscience Research Australia, Parkinson’s Disease Dementia, PDD: Parkinson's Disease with Dementia, Severe Neuroleptic Sensitivity, SPECT, Sydney, University of New South Wales, Visual Hallucinations | Leave a comment

Recent Systematic Reviews on Parkinson’s Disease (October – December 2012)

Posted on January 20, 2013 by Dementia and Elderly Care News

[A version of this collection appeared in Dementia and Elderly Care: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 5, January 2013]. Recent systematic reviews and meta-analyses concerning Parkinson’s Disease are shown below. Pan, PL. Shi, HC. Zhong, JG. [et al]. … Continue reading →

Posted in For Doctors (mostly), For Researchers (mostly), International, Parkinson's Disease, Systematic Reviews | Tagged Atrophy and Cognition, Cognitive Impairment in Parkinson's Disease, Driving, Grey-Matter Volume, Parkinson’s Disease Dementia, Parkinsonian Symptoms, Parkinsonism, Selected Systematic Reviews and Meta-Analyses | Leave a comment

Parkinson’s Disease Public Awareness Campaign (Parkinson’s UK, formerly the Parkinson’s Disease Society)

Posted on December 24, 2012 by Dementia and Elderly Care News

Summary Parkinson’s UK launched their first public awareness campaign earlier this month. The aim is to raise knowledge of the condition and improve understanding of the impact that Parkinson’s Disease has on sufferers. “Parkinson’s can affect messages the brain gives to … Continue reading →

Posted in Charitable Bodies, For Carers (mostly), For Nurses and Therapists (mostly), National, Parkinson's Disease, Quick Insights, UK, Universal Interest | Tagged Awareness, Awareness Raising, Campaigning, Cognitive Impairment in Parkinson's Disease, Dementia in Parkinson's Disease, Parkinson's Disease Public Awareness Campaign, Parkinson’s UK, Public Awareness (Parkinson's Disease) | Leave a comment

Cholinesterase Inhibitors for Dementia with Lewy Bodies, Parkinson’s Disease Dementia and Cognitive Impairment in Parkinson’s Disease (Cochrane Library)

Posted on April 4, 2012 by Dementia and Elderly Care News

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 9, April 2012]. Summary Earlier Cochrane reviews have examined the use of cholinesterase inhibitors in both Parkinson’s Disease with dementia (PDD) and dementia with … Continue reading →

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), Pharmacological Treatments, Systematic Reviews, Universal Interest | Tagged Acetylcholine, ADCS (Scale), ALOIS: the Cochrane Dementia and Cognitive Improvement Group, Behavioural Disturbance Rating Scales, Cholinesterase Inhibitors, CIND-PD: Cognitive Impairment in Parkinson's Disease, Cognitive Impairment in Parkinson's Disease, Cognitive Impairment in Parkinson's Disease (CIND-PD), Dementia with Lewy Bodies, DLB: Dementia with Lewy Bodies, Donepezil, Donepezil (Aricept), John Radcliffe Hospital, Mini Mental State Examination (MMSE), Oxford University Hospitals NHS Trust, Parkinson’s Disease Dementia, Parkinsonian Symptoms, PDD: Parkinson's Disease with Dementia, Rivastigmine, Unified Parkinson's Disease Rating Scale (UPDRS) | Leave a comment

Tag Archives: Cognitive Impairment in Parkinson’s Disease

Recent Systematic Reviews on Parkinson’s Disease (October – December 2012)

Parkinson’s Disease Public Awareness Campaign (Parkinson’s UK, formerly the Parkinson’s Disease Society)

Cholinesterase Inhibitors for Dementia with Lewy Bodies, Parkinson’s Disease Dementia and Cognitive Impairment in Parkinson’s Disease (Cochrane Library)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites